Our data suggest that, in addition to the known markers related to mesenchymal features (basal-like), the concomitant overexpression of MT1-MMP and downregulation of DDR1 expression should be considered as important biomarkers in the prognosis of breast carcinomas. The gene discussed is MMP14; the disease is breast carcinoma.